Related Experiment Video
Updated: Jun 25, 2025
10:10
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
8.7K
Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific Tregs
1Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PP, UK.
Cells
|May 24, 2024
Summary
Regulatory T cells show promise for treating multiple sclerosis (MS). Reprogramming these cells could suppress MS progression and repair central nervous system damage.
Area of Science:
- Neuroimmunology
- Cellular immunology
Background:
- Multiple sclerosis (MS) is an autoinflammatory disease causing neuronal damage.
- Current treatments are ineffective for progressive MS.
- Immune cells in the central nervous system (CNS) drive MS progression.
Purpose of the Study:
- Review recent advances in understanding regulatory T cells in MS.
- Explore the potential of genetically reprogrammed regulatory T cells for MS treatment.
Main Methods:
- Focus on T cell regulatory functions in MS.
- Discuss genetic reprogramming strategies for T cells.
Main Results:
- Regulatory T cells can suppress MS progression.
- These cells promote remyelination and repair of CNS lesions.
- Genetically reprogrammed T cells may offer localized immune suppression and repair.
Conclusions:
- Reprogrammed regulatory T cells hold potential for treating MS.
- Future therapies may involve persistent, specific T cell treatments for lasting disease suppression.
Keywords:
T cell receptoradoptive T cell therapyautoimmunityimmunotherapymultiple sclerosisregulatory T cellsMore Related Videos
Related Concept Videos
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515